SEC Form 4 · accession 0001562180-17-001441
Dermira, Inc. · DERM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eugene A Bauer
Officer — Chief Medical Officer · Director
Period of report
Apr 3, 2017
Accepted (ET)
Apr 4, 2017 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Apr 3, 2017 | S | 1,979 | $33.4039 | D | 42,499 | I | By the Bauer Family 1995 Trust |
| Common StockF4,F3 | Apr 3, 2017 | S | 521 | $34.0309 | D | 41,978 | I | By the Bauer Family 1995 Trust |
| Common StockF5 | holding | — | — | — | 3,489 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These trades were made pursuant to a Rule 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $32.97 to $33.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The Reporting Person is a Co-Trustee.
- F4This transaction was executed in multiple trades at prices ranging from $33.99 to $34.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5These shares include prior ESPP purchases.